‘How small- and mid-cap quoted companies make a substantial contribution to markets, employment and tax revenues’

Hardman & Co Report Report Downloads

Politicians and business leaders often refer to small and mid-size quoted companies (SMQCs) as being pivotal to the future of the British economy. But the definition of “small and mid-size” can cover a huge range of companies, and the difference between the UK’s largest companies and the rest is stark, as we present in this paper.
In particular, we examine the companies quoted on the UK’s public equity markets to highlight the difference in size between the largest 100 companies and the rest.
We also present data that show the massive contribution that SMQC make to our society and to the stock market.

In particular, we note the following for SMQCs.

► They represent 93% of all the companies quoted on the London Stock Exchange (LSE) by number (when investment companies and certain other categories are excluded – see ‘Our sample’ for more detail).

► They collectively have a market capitalisation of £428bn by value, representing 20% of the total market capitalisation of the LSE (with the same exclusions) .

► They employ over 3 million workers.

► They account for a substantial proportion of the workforce of all quoted companies in many regions of the UK.

► They contributed at least £26.5bn in taxes in 2017/18, we estimate, considering just Corporation Tax, Income Tax and National Insurance (NI), and ignoring VAT and Business Rates.

There does not appear to be a profile here yet (if this your your plc please get in touch)
Facebook
Twitter
LinkedIn
Hardman & Co

More articles like this

Team Internet plc

CentralNic Reseller WHMCS Modules

Our CentralNic Reseller WHMCS modules are designed to make selling domain names and services a breeze. As a preferred WHMCS partner, we provide thousands of resellers with free access to our state-of-the-art modules. With our extensive

hVIVO plc

Importance of Clinical Trials in the medical industry

Clinical trials play an important role in helping to ensure new drugs can be discovered, tested for safety and efficacy, and ultimately make their way onto the market. Over a million people took part in clinical trials during

Volta Finance

CLOs: One of the most underutilized asset classes

In the aftermath of the Global Financial Crisis (GFC), Collateralized Loan Obligations (CLOs) emerged as a contentious topic and were viewed through a cautious lens. However, as financial markets have evolved, the asset class has been

The evolution and future growth of Vanadium Redox Flow Batteries

The evolution of the redox flow battery over several decades has seen various chemistries being developed, commercialized, or even abandoned due to factors such as poor electrochemical reversibility and cross-contamination of active species. The vanadium redox

Avation plc

A growing partnership between ATR and Avation

During the worst days of the pandemic, many regional and remote communities relied on turboprops to deliver urgent medical personnel, supplies, and services and to keep them connected to the outside world, particularly in areas with

i(x) Net Zero plc

ESG market to surpass $40 trillion by 2030

The ESG market could surpass $40 trillion by 2030, based on our scenario analysis, anchoring the $140 trillion of projected assets under management (AUM) globally despite 70% slower growth and polarized sentiment. Scrutiny is critical as